{"AllianceGenome": "5432", "HGNC": "5432", "MIM": "107450", "_id": "3454", "_version": 1, "accession": {"genomic": ["AF039907.1", "AP000296.1", "AP000297.2", "AP000298.1", "AP001716.1", "AY654286.1", "CH471079.2", "CP068257.2", "KF510545.1", "NC_000021.9", "NC_060945.1", "X60459.1"], "protein": ["AAA52730.1", "AAH02590.1", "AAH21825.1", "AAT49100.1", "AFN73226.1", "AFN73227.1", "AFN73228.1", "AFN73229.1", "BAD96490.1", "BAD96532.1", "BAG35516.1", "BAG60345.1", "CAA42992.1", "EAX09837.1", "EAX09838.1", "EAX09839.1", "NP_000620.2", "NP_001371427.1", "NP_001371428.1", "NP_001371429.1", "NP_001371430.1", "NP_001371431.1", "NP_001371432.1", "NP_001371433.1", "P17181.3"], "rna": ["AK123813.1", "AK222770.1", "AK222812.1", "AK298051.1", "AK312631.1", "BC002590.2", "BC014338.1", "BC021825.1", "BC035603.1", "BC065751.1", "BG116121.1", "BG548299.1", "BX537636.1", "CA309858.1", "J03171.1", "JN543953.1", "JN543954.1", "JN543955.1", "JN543956.1", "NM_000629.3", "NM_001384498.1", "NM_001384499.1", "NM_001384500.1", "NM_001384501.1", "NM_001384502.1", "NM_001384503.1", "NM_001384504.1", "R15745.1"], "translation": [{"protein": "BAD96532.1", "rna": "AK222812.1"}, {"protein": "AAH02590.1", "rna": "BC002590.2"}, {"protein": "AFN73229.1", "rna": "JN543956.1"}, {"protein": "NP_001371429.1", "rna": "NM_001384500.1"}, {"protein": "BAG35516.1", "rna": "AK312631.1"}, {"protein": "NP_001371428.1", "rna": "NM_001384499.1"}, {"protein": "NP_001371432.1", "rna": "NM_001384503.1"}, {"protein": "AAA52730.1", "rna": "J03171.1"}, {"protein": "NP_001371433.1", "rna": "NM_001384504.1"}, {"protein": "NP_001371430.1", "rna": "NM_001384501.1"}, {"protein": "AFN73226.1", "rna": "JN543953.1"}, {"protein": "AFN73227.1", "rna": "JN543954.1"}, {"protein": "NP_001371427.1", "rna": "NM_001384498.1"}, {"protein": "AFN73228.1", "rna": "JN543955.1"}, {"protein": "NP_000620.2", "rna": "NM_000629.3"}, {"protein": "BAD96490.1", "rna": "AK222770.1"}, {"protein": "BAG60345.1", "rna": "AK298051.1"}, {"protein": "AAH21825.1", "rna": "BC021825.1"}, {"protein": "NP_001371431.1", "rna": "NM_001384502.1"}]}, "alias": ["AVP", "IFN-alpha-REC", "IFNAR", "IFNBR", "IFRC", "IMD106"], "ensembl": {"gene": "ENSG00000142166", "protein": ["ENSP00000270139", "ENSP00000400161", "ENSP00000498231", "ENSP00000498491", "ENSP00000498594", "ENSP00000498654", "ENSP00000498666", "ENSP00000514762", "ENSP00000514785", "ENSP00000514786", "ENSP00000515347", "ENSP00000515348", "ENSP00000515349", "ENSP00000515372", "ENSP00000515373", "ENSP00000515377", "ENSP00000515378", "ENSP00000515379", "ENSP00000515380", "ENSP00000515381", "ENSP00000515477"], "transcript": ["ENST00000270139", "ENST00000442071", "ENST00000651609", "ENST00000652450", "ENST00000652513", "ENST00000652601", "ENST00000652654", "ENST00000700045", "ENST00000700046", "ENST00000700080", "ENST00000700084", "ENST00000700085", "ENST00000700086", "ENST00000700087", "ENST00000700099", "ENST00000700301", "ENST00000703514", "ENST00000703515", "ENST00000703516", "ENST00000703556", "ENST00000703557", "ENST00000703561", "ENST00000703562", "ENST00000703563", "ENST00000703564", "ENST00000703565", "ENST00000703776", "ENST00000703778", "ENST00000703779"], "translation": [{"protein": "ENSP00000514785", "rna": "ENST00000700080"}, {"protein": "ENSP00000498654", "rna": "ENST00000652450"}, {"protein": "ENSP00000514786", "rna": "ENST00000700084"}, {"protein": "ENSP00000498666", "rna": "ENST00000652654"}, {"protein": "ENSP00000515348", "rna": "ENST00000703515"}, {"protein": "ENSP00000515372", "rna": "ENST00000703556"}, {"protein": "ENSP00000515373", "rna": "ENST00000703557"}, {"protein": "ENSP00000498491", "rna": "ENST00000652513"}, {"protein": "ENSP00000515381", "rna": "ENST00000703565"}, {"protein": "ENSP00000515347", "rna": "ENST00000703514"}, {"protein": "ENSP00000515378", "rna": "ENST00000703562"}, {"protein": "ENSP00000515377", "rna": "ENST00000703561"}, {"protein": "ENSP00000400161", "rna": "ENST00000442071"}, {"protein": "ENSP00000514762", "rna": "ENST00000700046"}, {"protein": "ENSP00000515379", "rna": "ENST00000703563"}, {"protein": "ENSP00000270139", "rna": "ENST00000270139"}, {"protein": "ENSP00000498231", "rna": "ENST00000652601"}, {"protein": "ENSP00000515349", "rna": "ENST00000703516"}, {"protein": "ENSP00000515477", "rna": "ENST00000703779"}, {"protein": "ENSP00000498594", "rna": "ENST00000651609"}, {"protein": "ENSP00000515380", "rna": "ENST00000703564"}], "type_of_gene": "protein_coding"}, "entrezgene": "3454", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 16.8639088437, "exp_mis": 163.197734004, "exp_syn": 74.5201835701, "lof_z": 2.13813863804398, "mis_z": -1.02619882466148, "mu_lof": 1.12214162142e-06, "mu_mis": 1.4614006936e-05, "mu_syn": 6.55879191745e-06, "n_lof": 8.0, "n_mis": 190.0, "n_syn": 74.0, "p_li": 0.000620329691645639, "p_null": 0.0229184340904316, "p_rec": 0.976461236217923, "syn_z": 0.0373564995198307}, "bp": 1674, "cds_end": 34727855, "cds_start": 34697360, "n_exons": 11, "nonpsych": {"exp_lof": 15.0448281598, "exp_mis": 147.491065024, "exp_syn": 67.229319691, "lof_z": 2.2901222961533, "mis_z": -1.01789402246279, "mu_lof": 1.12214162142e-06, "mu_mis": 1.4614006936e-05, "mu_syn": 6.55879191745e-06, "n_lof": 6.0, "n_mis": 172.0, "n_syn": 67.0, "p_li": 0.00974482144335865, "p_null": 0.0131055138491191, "p_rec": 0.977149664707522, "syn_z": 0.0176086502428245}, "nontcga": {"exp_lof": 15.4934852723, "exp_mis": 150.120614679, "exp_syn": 68.5372594859, "lof_z": 2.1285930125478, "mis_z": -1.09297189946172, "mu_lof": 1.12214162142e-06, "mu_mis": 1.4614006936e-05, "mu_syn": 6.55879191745e-06, "n_lof": 7.0, "n_mis": 177.0, "n_syn": 67.0, "p_li": 0.0020147227577261, "p_null": 0.0208630581559114, "p_rec": 0.977122219086363, "syn_z": 0.117572632401127}, "transcript": "ENST00000270139.3"}, "exons": [{"cdsend": 33355549, "cdsstart": 33325055, "chr": "21", "position": [[33324969, 33325131], [33335523, 33335647], [33340998, 33341174], [33343267, 33343422], [33343534, 33343676], [33345245, 33345360], [33349090, 33349290], [33349388, 33349543], [33352757, 33352908], [33353637, 33353783], [33355315, 33359864]], "strand": 1, "transcript": "NM_000629", "txend": 33359864, "txstart": 33324969}, {"cdsend": 33357759, "cdsstart": 33325055, "chr": "21", "position": [[33324969, 33325131], [33335523, 33335647], [33340998, 33341174], [33343267, 33343422], [33343534, 33343676], [33345245, 33345360], [33349090, 33349290], [33349388, 33349543], [33352757, 33352908], [33353637, 33353783], [33355315, 33355533], [33357740, 33359864]], "strand": 1, "transcript": "NM_001384498", "txend": 33359864, "txstart": 33324969}, {"cdsend": 33355326, "cdsstart": 33325055, "chr": "21", "position": [[33324969, 33325131], [33335523, 33335647], [33340998, 33341174], [33343267, 33343422], [33343534, 33343676], [33345245, 33345360], [33349090, 33349290], [33349388, 33349543], [33352757, 33352908], [33355315, 33359864]], "strand": 1, "transcript": "NM_001384499", "txend": 33359864, "txstart": 33324969}, {"cdsend": 33355549, "cdsstart": 33345334, "chr": "21", "position": [[33324969, 33325131], [33335523, 33335647], [33340998, 33341174], [33343267, 33343422], [33343510, 33343676], [33345245, 33345360], [33349090, 33349290], [33349388, 33349543], [33352757, 33352908], [33353637, 33353783], [33355315, 33359864]], "strand": 1, "transcript": "NM_001384500", "txend": 33359864, "txstart": 33324969}, {"cdsend": 33355549, "cdsstart": 33325055, "chr": "21", "position": [[33324969, 33325131], [33335523, 33335647], [33340998, 33341174], [33343267, 33343422], [33343534, 33343676], [33345245, 33345360], [33349105, 33349290], [33349388, 33349543], [33352757, 33352908], [33353637, 33353783], [33355330, 33359864]], "strand": 1, "transcript": "NM_001384501", "txend": 33359864, "txstart": 33324969}, {"cdsend": 33355549, "cdsstart": 33343353, "chr": "21", "position": [[33324969, 33325131], [33335523, 33335647], [33341077, 33341174], [33343267, 33343422], [33343534, 33343676], [33345245, 33345360], [33349090, 33349290], [33349388, 33349543], [33352757, 33352908], [33353637, 33353783], [33355315, 33359864]], "strand": 1, "transcript": "NM_001384502", "txend": 33359864, "txstart": 33324969}, {"cdsend": 33355549, "cdsstart": 33325055, "chr": "21", "position": [[33324969, 33325131], [33335523, 33335647], [33340998, 33341174], [33343267, 33343422], [33343534, 33343676], [33345245, 33345360], [33349090, 33349290], [33349388, 33349543], [33352757, 33352908], [33353637, 33353783], [33355330, 33359864]], "strand": 1, "transcript": "NM_001384503", "txend": 33359864, "txstart": 33324969}, {"cdsend": 33355549, "cdsstart": 33341005, "chr": "21", "position": [[33324394, 33324638], [33335523, 33335647], [33340998, 33341174], [33343267, 33343422], [33343534, 33343676], [33345245, 33345360], [33349090, 33349290], [33349388, 33349543], [33352757, 33352908], [33353637, 33353783], [33355315, 33359864]], "strand": 1, "transcript": "NM_001384504", "txend": 33359864, "txstart": 33324394}], "exons_hg19": [{"cdsend": 34727855, "cdsstart": 34697360, "chr": "21", "position": [[34697274, 34697436], [34707829, 34707953], [34713304, 34713480], [34715573, 34715728], [34715840, 34715982], [34717551, 34717666], [34721396, 34721596], [34721694, 34721849], [34725063, 34725214], [34725943, 34726089], [34727621, 34732170]], "strand": 1, "transcript": "NM_000629", "txend": 34732170, "txstart": 34697274}, {"cdsend": 34730065, "cdsstart": 34697360, "chr": "21", "position": [[34697274, 34697436], [34707829, 34707953], [34713304, 34713480], [34715573, 34715728], [34715840, 34715982], [34717551, 34717666], [34721396, 34721596], [34721694, 34721849], [34725063, 34725214], [34725943, 34726089], [34727621, 34727839], [34730046, 34732170]], "strand": 1, "transcript": "NM_001384498", "txend": 34732170, "txstart": 34697274}, {"cdsend": 34727632, "cdsstart": 34697360, "chr": "21", "position": [[34697274, 34697436], [34707829, 34707953], [34713304, 34713480], [34715573, 34715728], [34715840, 34715982], [34717551, 34717666], [34721396, 34721596], [34721694, 34721849], [34725063, 34725214], [34727621, 34732170]], "strand": 1, "transcript": "NM_001384499", "txend": 34732170, "txstart": 34697274}, {"cdsend": 34727855, "cdsstart": 34717640, "chr": "21", "position": [[34697274, 34697436], [34707829, 34707953], [34713304, 34713480], [34715573, 34715728], [34715816, 34715982], [34717551, 34717666], [34721396, 34721596], [34721694, 34721849], [34725063, 34725214], [34725943, 34726089], [34727621, 34732170]], "strand": 1, "transcript": "NM_001384500", "txend": 34732170, "txstart": 34697274}, {"cdsend": 34727855, "cdsstart": 34697360, "chr": "21", "position": [[34697274, 34697436], [34707829, 34707953], [34713304, 34713480], [34715573, 34715728], [34715840, 34715982], [34717551, 34717666], [34721411, 34721596], [34721694, 34721849], [34725063, 34725214], [34725943, 34726089], [34727636, 34732170]], "strand": 1, "transcript": "NM_001384501", "txend": 34732170, "txstart": 34697274}, {"cdsend": 34727855, "cdsstart": 34715659, "chr": "21", "position": [[34697274, 34697436], [34707829, 34707953], [34713383, 34713480], [34715573, 34715728], [34715840, 34715982], [34717551, 34717666], [34721396, 34721596], [34721694, 34721849], [34725063, 34725214], [34725943, 34726089], [34727621, 34732170]], "strand": 1, "transcript": "NM_001384502", "txend": 34732170, "txstart": 34697274}, {"cdsend": 34727855, "cdsstart": 34697360, "chr": "21", "position": [[34697274, 34697436], [34707829, 34707953], [34713304, 34713480], [34715573, 34715728], [34715840, 34715982], [34717551, 34717666], [34721396, 34721596], [34721694, 34721849], [34725063, 34725214], [34725943, 34726089], [34727636, 34732170]], "strand": 1, "transcript": "NM_001384503", "txend": 34732170, "txstart": 34697274}, {"cdsend": 34727855, "cdsstart": 34713311, "chr": "21", "position": [[34696699, 34696943], [34707829, 34707953], [34713304, 34713480], [34715573, 34715728], [34715840, 34715982], [34717551, 34717666], [34721396, 34721596], [34721694, 34721849], [34725063, 34725214], [34725943, 34726089], [34727621, 34732170]], "strand": 1, "transcript": "NM_001384504", "txend": 34732170, "txstart": 34696699}], "generif": [{"pubmed": 12220192, "text": "Only the tyrosine-phosphorylated form of interferon alpha receptor subunit 1 binds to Stat2."}, {"pubmed": 12554654, "text": "Data show that Tyk2 tyrosine kinase is essential for stable cell surface expression of IFNAR1."}, {"pubmed": 12618863, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12620806, "text": "Measles virus suppresses interferon-alpha signaling pathway: association of viral accessory proteins, C and V, with interferon-alpha receptor complex"}, {"pubmed": 12697242, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12761564, "text": "An association has been demonstrated between two IFNAR1 polymorphisms and cerebral malaria."}, {"pubmed": 12761564, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14532120, "text": "IFNAR1 interacts with the Homolog of Slimb (HOS) F-box protein in a phosphorylation-dependent manner, and that this interaction is promoted by interferon alpha"}, {"pubmed": 14647450, "text": "IFNAR1 and IFNAR2 levels reveal that the KAS-6/1 cell line overexpresses IFNAR1 relative to other myeloma cell lines that are growth arrested by IFN-alpha."}, {"pubmed": 14727154, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15063762, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15337770, "text": "phosphorylation and ubiquitin acceptor sites are required for ubiquitination and degradation of IFNAR1"}, {"pubmed": 15449939, "text": "A dynamic model for the IFN-alpha/receptor complex predicts that IFNAR1 and IFNAR2 are probably anchored in close proximity on the cell surface and that upon IFN binding, the complex assumes a closed form, resulting in activation of intracellular kinases."}, {"pubmed": 15589821, "text": "The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence."}, {"pubmed": 15885318, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15946680, "text": "analysis of the roles of the four Ig-like sub-domains (SDs) of the extracellular domain of ifnar1 (ifnar1-EC) for ligand recognition and receptor assembling"}, {"pubmed": 15990456, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15990456, "text": "The promoter GT repeat dinucleotide microsatellite polymorphism of the IFNAR1 gene may represent a risk factor for the development of depressive symptoms during IFN-alpha therapy for hepatitis C and other conditions."}, {"pubmed": 16171819, "text": "Data describe the mapping of the complete binding region of IFNAR1 on IFNalpha2 using a panel of 21 single alanine mutant proteins."}, {"pubmed": 16338279, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16624932, "text": "Monocyte-derived dendritic cells can modulate their sensitivity to two IFN subtypes through a differential regulation of the IFNAR subunits."}, {"pubmed": 17001036, "text": "Human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex."}, {"pubmed": 17027223, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17125879, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17125879, "text": "Polymorphisms of IFNAR1 promoter may affect, at least in part, the outcomes of HBV infection."}, {"pubmed": 17310065, "text": "constructed a phage display library by randomizing three positions on IFNalpha2 previously shown to confer weak binding to IFNAR1"}, {"pubmed": 17517919, "text": "Data describe the species specificity of IFN-alphas, the residues in murine IFN-alpha4 that preclude strong affinity interactions with human IFNAR1 and 2, and residues in human IFN-alpha8 that resemble a receptor interactive domain in murine IFN-alpha4."}, {"pubmed": 17667505, "text": "The intensity and distribution of IFNAR-1 may predict the response to therapy with IFN-alpha and IFN-beta in pancreatic cancer."}, {"pubmed": 17703412, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17823081, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17823081, "text": "This study suggests that when combination therapy with high dose IFN-alpha and ribavirin is administered, HCV genotypes and age rather than the IFNAR1 polymorphisms are the predictors of a sustained response."}, {"pubmed": 17923090, "text": "report that in response to type 1 interferon (IFNalpha), IFNalpha type 1 receptors recruit cytoplasmic CREB-binding protein (CBP)."}, {"pubmed": 18056411, "text": "Ubiquitination of IFNAR1 promotes its interaction with the adaptin complex that is required for the robust internalization of IFNAR1, implicating cooperation between site-specific ubiquitination and the linear endocytic motif in regulating this process."}, {"pubmed": 18166147, "text": "We discuss the signaling events that might lead to ubiquitination and degradation of IFNAR1 via ligand-dependent and independent pathways and their potential physiologic significance."}, {"pubmed": 18250407, "text": "An IFNAR1/retinoic acid-inducible gene I (RIG-I)-dependent pathway mediates SOCS1 and SOCS3 up-regulation in influenza A virus-infected bronchial epithelial cells."}, {"pubmed": 18338947, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18362156, "text": "place TRAF2 directly in the signaling pathway transduced through the IFNAR1 subunit of the IFN receptor"}, {"pubmed": 18474601, "text": "Tyk2 contributes to both the regulation of total IFNAR1 levels as well as the regulation of the cell surface density of this receptor chain."}, {"pubmed": 18535656, "text": "a major bottleneck was observed during POLIOVIRUS transit to the brain in PVR mice, but was absent in PVR-IFNAR-/- mice, suggesting that the interferon response was a determinant of the peripheral site-to-brain bottleneck"}, {"pubmed": 18761606, "text": "In conclusion, IFNAR1 19158C/G polymorphism is primarily associated with susceptibility to chronic HBV infection."}, {"pubmed": 18761606, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18801736, "text": "the stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities"}, {"pubmed": 18937499, "text": "Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists."}, {"pubmed": 18953482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19103527, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19103527, "text": "two variants of the IFNAR1 gene are associated with the clinical presentation of hepatitis B virus infection"}, {"pubmed": 19124753, "text": "CD11c-Cre+/- ifnar1(fl/fl) transgenic mice respond with vigorous IFN-alpha production to mouse hepatitis virus infection, suggesting that lack of IFNAR on plasmacytoid dendritic cells has no significant impact on the early type I IFN response."}, {"pubmed": 19220955, "text": "The expression of interferon-alpha receptor in liver tissues in patients with chronic hepatitis B correlates well with the pathological grading and alanine aminotransferase level."}, {"pubmed": 19258923, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19299650, "text": "Defective monocyte responses to IFNalpha/beta may play an important role in the pathogenesis of HIV-1 infection, and decreased IFNalpha/betaR expression may serve as a novel marker of disease progression."}, {"pubmed": 19434718, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19501422, "text": "Upon HBV infection, decreased binding affinity of HMGB1 to the IFNAR1 promoter -3T variant is aggravated by the suppressed PARP-1 expression caused by HBV, resulting in a further attenuated IFNAR1 expression."}, {"pubmed": 19559055, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19561067, "text": "Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha."}, {"pubmed": 19730683, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19773451, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19796549, "text": "IFNAR1 (interferon-alpha receptor 1) (G/C in SNP18417) and IFNAR1 (interferon-alpha receptor 2) (G/T in SNP 11876) polymorphisms jointly, but not individually, may confer susceptibility to Behcets disease in a Turkish population"}, {"pubmed": 19805514, "text": "Results suggest a role for mammalian and parasite casein kinase 1alpha in regulating IFNAR1 stability and type I IFN signaling."}, {"pubmed": 19817957, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19879773, "text": "These results suggest that a combination of serum soluble interferon-alpha/beta receptor and high-sensitivity-CRP thresholds may be more reliable diagnostic parameter for gastrointestinal and hepatobiliary-pancreatic cancer."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19948722, "text": "Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation"}, {"pubmed": 19957332, "text": "Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death."}, {"pubmed": 20020050, "text": "The 3a protein was found to induce serine phosphorylation within the IFN alpha-receptor subunit 1 (IFNAR1) degradation motif and to increase IFNAR1 ubiquitination."}, {"pubmed": 20065083, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20331378, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20378664, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20503287, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20565290, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20588308, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20811626, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 21173164, "text": "Expression and kinase activity of PKD2 are required for the ligand-inducible stimulation of IFNAR1 ubiquitination and endocytosis and for accelerated proteolytic turnover of IFNAR1."}, {"pubmed": 21540188, "text": "an important role of p38 kinase in the ligand-independent stimulation of IFNAR1 ubiquitination and degradation"}, {"pubmed": 21690295, "text": "A low number of receptors suffices for antiviral response and is thus a robust feature common to all cells. Conversely, a high number of receptors is required for antiproliferative activity, which allows for fine-tuning on a single-cell level."}, {"pubmed": 21695243, "text": "activation of p38 kinase in response to pathogen-recognition receptors stimulation results in a series of phosphorylation events within the IFNAR1 chain of the Type I IFN receptor"}, {"pubmed": 21716316, "text": "CLC and IFNAR1 were identified to be overall differentially expressed between early- and late-onset CRC, and are important in the development of early-onset CRC."}, {"pubmed": 21756311, "text": "The results of this study suggest that expression of cell surface IFNAR1 is critical for the response of hepatitis C virus to exogenous interferon alpha."}, {"pubmed": 21757742, "text": "The consequent effect of SOCS1 inhibition of Tyk2 not only results in a reduced IFN response because of inhibition of Tyk2 kinase-mediated STAT signaling but also negatively impacts IFNAR1 surface expression, which is stabilized by Tyk2."}, {"pubmed": 21821707, "text": "Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNalpha via accelerating the degradation of its receptor."}, {"pubmed": 21830897, "text": "These data demonstrate that West Nile virus infection results in a reduction of IFNAR1 protein through a non-canonical protein degradation pathway, and may participate in the inhibition of the interferon response."}, {"pubmed": 21832278, "text": "In cells exposed to VEGF, phosphorylation-dependent degradation of IFNAR1 leads to an inhibition of type 1 IFN signaling and is required for efficient VEGF-stimulated angiogenesis."}, {"pubmed": 21865166, "text": "Tyrosine phosphorylation of PKD2 is required for IFNalpha-stimulated activation of this kinase as well as for efficient serine phosphorylation and degradation of IFNAR1 and ensuing restriction of the extent of cellular responses to IFNalpha."}, {"pubmed": 22036215, "text": "Systemic lupus erythematosus patients are found to have the highest serum type I IFN activity; in contrast, the untreated relapsing-remitting multiple sclerosis population has the lowest levels of endogenous IFN-alpha/beta activity."}, {"pubmed": 22136495, "text": "Early progenitors and mature megakaryocytes, but not platelets, express functional IFNAR and synthetize/release IFN-beta, revealing not only that megakaryo/thrombopoiesis regulation by IFN-I is associated with a specific interaction with its receptor"}, {"pubmed": 22156349, "text": "IFNalphaR is dispensable on responding CD4+ T cells. Cells derived from transgenic bone marrow are sufficient to restore IFNalphaR-dependent pathways in IFNalphaR-deficient mice."}, {"pubmed": 22162633, "text": "Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes."}, {"pubmed": 22218495, "text": "HBX expression downregulates type I IFN receptor, leading to disturbance of extracellular type I IFN signaling."}, {"pubmed": 22258259, "text": "2A protease encoded by EV71 as an antagonist of IFNB1 and the protease activity is required for reducing IFNAR1 levels."}, {"pubmed": 22786773, "text": "These new findings reveal distinct and overlapping signaling mechanisms used by B-cell antigen receptor and IFNAR in the regulation of TLR7 tolerance and activation."}, {"pubmed": 22824466, "text": "common genetic changes in IFNAR1 may influence HCC risk, likely through miR-1231-mediated regulation."}, {"pubmed": 23129613, "text": "PTP1B is a specific regulator of IFNAR1 endocytosis."}, {"pubmed": 23201923, "text": "[review] The type I interferon system has an important role in the pathogenesis of Sjogren's syndrome."}, {"pubmed": 23209811, "text": "Results identified genetic variants in interferon genes that influence melanoma progression and survival with modulation of effect due to treatment status."}, {"pubmed": 23663046, "text": "Results suggest that oxidative stress play an important role in the regulation of type I interferon receptors IFNAR1 and IFNAR2 in chronic hepatitis B virus (HBV) infection."}, {"pubmed": 24334027, "text": "These data indicate that type I IFN, via an action of IFNAR1, mediates pulmonary arterial hypertension."}, {"pubmed": 24460759, "text": "Therefore, this study associated, for the first time, in a large panel of pancreatic cancer cell lines the effects of IFN-alpha/-beta with the expression of type-I IFN receptors."}, {"pubmed": 24704786, "text": "The crystal structure of a receptor-binding fragment of human TYK2, encompassing the FERM and SH2 domains, in complex with peptide motif from the interferon-alpha receptor chain 1 (IFNAR1) is presented."}, {"pubmed": 25072284, "text": "A small proportion of both pancreatic and periampullary tumors showed a strong expression of the IFNAR-1."}, {"pubmed": 25265476, "text": "The expression of IFNAR1, IFNgammaR1 and ribovarin transporters were significantly impaired in chronic liver disease and cirrhotic livers."}, {"pubmed": 25445652, "text": "Results show that SNPs in IFNAR1 and IFNG were risk factors for malaria in Indian population."}, {"pubmed": 25501140, "text": "sequence variants of both the IFNAR1-17470 and IL-10-592 genes were correlated with susceptibility to chronic hepatitis B."}, {"pubmed": 25675103, "text": "IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients"}, {"pubmed": 25939635, "text": "Genetic polymorphisms of the promoter of INFAR gene represent important factors associated with the clinical phase of HBeAg-negative chronic HBV infection."}, {"pubmed": 26008745, "text": "Dimerization of IFNAR1 and IFNAR2 and the limiting role of IFNAR1 binding affinity in complex assembly is modulated by USP18."}, {"pubmed": 26159719, "text": "Prolidase was required for IFNAR1 maturation and accumulation, activation of IFNbeta-stimulated gene induction, and IFN-I-dependent viral control."}, {"pubmed": 26429320, "text": "this study shows that single nucleotide polymorphism in IFNAR1 gene is associated with female vitiligo in Estonian patients"}, {"pubmed": 26676772, "text": "These findings suggest that influenza A virus hemagglutinin causes IFNAR1 degradation, which in turn helps the virus escape the powerful innate immune system."}, {"pubmed": 26679744, "text": "rs2843710 of IFNAR1 was associated with the susceptibility and severity of EV71 HFMD in Chinese Han populations."}, {"pubmed": 26679999, "text": "Data suggest IFNA2 (interferon, alpha 2) binding to extracellular domain of IFNAR1 or IFNAR2 promotes proximity between intracellular domains; signaling depends on duration of activation/affinity of binding rather than specific conformational changes."}, {"pubmed": 26787880, "text": "data illustrate a lipid G-protein coupled receptor (GPCR)-IFNAR1 regulatory loop that balances effective and detrimental immune responses and elevated endogenous S1PR1 signaling"}, {"pubmed": 27346865, "text": "the level of IFNAR1, IFNAR2, and CCR5 mRNA expression was found to be significantly lower in the responders than nonresponders.Our results highlighted the significance of IFNAR and CCR5 genes in multiple sclerosis risk and the response to IFN-b therapy."}, {"pubmed": 27569280, "text": "These results suggest that miR-29a, upregulated during RSV infection, is a negative regulator of IFNAR1 and is critical for respiratory syncytial virus NS1-induced virus replication."}, {"pubmed": 28122987, "text": "On one hand, hepatitis B virus activates MMP-9 in infected patients and leukocytes. On the other hand, MMP-9 facilitates hepatitis B virus replication through repressing IFN/JAK/STAT signaling, IFNAR1 function, and IFN-alpha action."}, {"pubmed": 28196594, "text": "Downregulation of IFNAR1 in tumor stroma stimulated colorectal cancer development and growth, played a key role in formation of the immune-privileged niche."}, {"pubmed": 28282804, "text": "Relapsing-remitting multiple sclerosis patients manifested a statistically higher expression level of IFNAR1 than their normal counterparts."}, {"pubmed": 28576494, "text": "Here, we review the current knowledge on the main strategies that human pathogenic flaviviruses utilize to escape both type I IFN induction and effector pathways.  [review]"}, {"pubmed": 28583475, "text": "The authors find that UCHL3 regulates COPS5-dependent deneddylation of Cullin1, which is an essential component of SCF(beta-TrCP) complex and associated with SCF(beta-TrCP) activities. The authors further demonstrate that UCHL3 upregulates the levels of SCF(beta-TrCP) substrates including IFN-I receptor IFNAR1, which enhances IFN-I mediated signaling pathway and antiviral activity."}, {"pubmed": 28842285, "text": "Low IFNAR1 expression is associated with peritoneal metastasis in gastric cancer."}, {"pubmed": 29106381, "text": "A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations."}, {"pubmed": 29311663, "text": "IFNAR1 signaling underlies an increased risk of tuberculosis in humans and reveals a function for the IFNAR1 inter-domain region in cytokine-cytokine receptor interaction and signal transduction."}, {"pubmed": 29343571, "text": "cellular kinase, casein kinase 1alpha (CK1alpha), is crucial for IAV HA-induced degradation of both IFNGR1 and IFNAR1."}, {"pubmed": 29375208, "text": "HCV-1b core protein-induced miR-93-5p up-regulation inhibits the IFN signaling pathway by directly targeting IFNAR1, and the miR-93-5p-IFNAR1 axis regulates STAT1 phosphorylation."}, {"pubmed": 29637882, "text": "A IFNAR1 protective variant, rs914142, is associated with lower expression of IFNAR1, whereas the Cerebral malaria (CM)-associated variant rs12626750 was associated with increased IFNAR1 expression, suggesting that activation of the type I IFN pathway may contribute to pathogenesis of CM."}, {"pubmed": 29713327, "text": "The IFNAR-1 promoter polymorphisms are not involved in the expression levels of the main IFNAR-1 transcript. The -77VNTR has a regulatory role on the expression of a secondary, truncated, HCC-specific transcript, which in turn coincides with disruptions in cancer-associated pathways and in FN-1 expression modifications."}, {"pubmed": 30383464, "text": "results indicated that the IFNAR promoter methylation might have a potential relationship with the status of oxidative stress"}, {"pubmed": 30410131, "text": "Our results show that levels of IFNAR-1 mRNA expression may be a good predictor for IFN-related anti-viral activity in both HCV mono infected and HCV/HBV co-infected patients."}, {"pubmed": 30555157, "text": "Overexpression of IFNAR1, MX1 and signal transducer and activator of transcription 1 (Stat1) indicated the endogenous IFNa activation in tumour microenvironment, which correlated with immunosuppression status in head and neck squamous cell carcinomas (HNSCC) patients"}, {"pubmed": 30645975, "text": "Data suggest that IFNAR1-mediated expression of CH25H in healthy tissues limits the extent of education of these tissues by tumor-derived extracellular vesicles (TEV) and restricts the formation of the pre-metastatic niche in the lungs. Accordingly, these results suggest a defensive role of the IFNAR1-CH25H pathway against the development of distant lung metastases."}, {"pubmed": 31270247, "text": "complete IFNAR1 deficiency can result in life-threatening complications of vaccination with live attenuated measles and Yellow fever viruses in previously healthy individuals."}, {"pubmed": 31298317, "text": "MicroRNA-93-5p/IFNAR1 axis accelerates metastasis of endometrial carcinoma by activating the STAT3 pathway."}, {"pubmed": 31512106, "text": "Cellular Caspase-3 Contributes to EV-A71 2A(pro)-Mediated Down-Regulation of IFNAR1 at the Translation Level."}, {"pubmed": 32960813, "text": "Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency."}, {"pubmed": 33583067, "text": "MicroRNA-29s suppressed both soluble ST2 release and IFNAR1 expression in human bronchial epithelial cells."}, {"pubmed": 33746965, "text": "Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection."}, {"pubmed": 33807175, "text": "Rotavirus NSP1 Inhibits Type I and Type III Interferon Induction."}, {"pubmed": 33811647, "text": "TRIM10 binds to IFN-alpha/beta receptor 1 to negatively regulate type I IFN signal transduction."}, {"pubmed": 34328599, "text": "Association study of promoter polymorphisms of interferon alpha and beta receptor subunit 1 (IFNAR1) gene and therapeutic response to interferon-beta in patients with multiple sclerosis."}, {"pubmed": 34713375, "text": "A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19."}, {"pubmed": 34794508, "text": "IFNAR1 gene mutation may contribute to developmental stuttering in the Chinese population."}, {"pubmed": 34813358, "text": "IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs."}, {"pubmed": 34899713, "text": "Congenital Zika Syndrome Is Associated With Interferon Alfa Receptor 1."}, {"pubmed": 35048182, "text": "ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis."}, {"pubmed": 35288721, "text": "Ifnar gene variants influence gut microbial production of palmitoleic acid and host immune responses to tuberculosis."}, {"pubmed": 35339044, "text": "Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients."}, {"pubmed": 35442418, "text": "A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes."}, {"pubmed": 35708626, "text": "Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia."}, {"pubmed": 35816776, "text": "Beyond fusion: A novel role for ERVW-1 in trophoblast proliferation and type I interferon receptor expression."}, {"pubmed": 35985475, "text": "CK1alpha upregulates the IFNAR1 expression to prompt the anti-HBV effect of type I IFN in hepatoma carcinoma cells."}, {"pubmed": 36063748, "text": "Correlation between IFNAR1 expression in peripheral blood T lymphocytes and inflammatory cytokines, tumor-infiltrating lymphocytes, and chemosensitivity in patients with colorectal cancer."}, {"pubmed": 37028439, "text": "Association of IFNAR1 and IFNAR2 with COVID-19 severity."}, {"pubmed": 37973454, "text": "Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386 * variant by tri-allelic genotyping."}], "genomic_pos": {"chr": "21", "end": 33359864, "ensemblgene": "ENSG00000142166", "start": 33324387, "strand": 1}, "genomic_pos_hg19": {"chr": "21", "end": 34732168, "start": 34696734, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0007259", "pubmed": [7526154, 7657660, 7813427, 8605876], "qualifier": "involved_in", "term": "cell surface receptor signaling pathway via JAK-STAT"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0009615", "pubmed": 2153461, "qualifier": "involved_in", "term": "response to virus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032496", "qualifier": "involved_in", "term": "response to lipopolysaccharide"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035457", "qualifier": "involved_in", "term": "cellular response to interferon-alpha"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035458", "pubmed": 7813427, "qualifier": "involved_in", "term": "cellular response to interferon-beta"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046425", "qualifier": "involved_in", "term": "regulation of receptor signaling pathway via JAK-STAT"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060337", "qualifier": "involved_in", "term": "type I interferon-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060337", "pubmed": [7665574, 21854986], "qualifier": "involved_in", "term": "type I interferon-mediated signaling pathway"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0060337", "pubmed": 30936491, "qualifier": "involved_in", "term": "type I interferon-mediated signaling pathway"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0098586", "pubmed": 30936491, "qualifier": "involved_in", "term": "cellular response to virus"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1901857", "pubmed": 25930096, "qualifier": "involved_in", "term": "positive regulation of cellular respiration"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005764", "qualifier": "located_in", "term": "lysosome"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005770", "qualifier": "located_in", "term": "late endosome"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 14532120, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0005886", "pubmed": 35442418, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004905", "qualifier": "enables", "term": "type I interferon receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004905", "pubmed": [7665574, 7813427, 21854986], "qualifier": "enables", "term": "type I interferon receptor activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0004905", "pubmed": [31270247, 33252644, 35442418], "qualifier": "enables", "term": "type I interferon receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [7665574, 8605876, 9121453, 9677371, 12220192, 14532120, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008269", "pubmed": 8605876, "qualifier": "enables", "term": "JAK pathway signal transduction adaptor activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008269", "pubmed": 34813358, "qualifier": "enables", "term": "JAK pathway signal transduction adaptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019955", "pubmed": 7813427, "qualifier": "enables", "term": "cytokine binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0019962", "qualifier": "enables", "term": "type I interferon binding"}]}, "homologene": {"genes": [[7955, 619391], [8364, 100498552], [9031, 395665], [9544, 699604], [9598, 458516], [9606, 3454], [9615, 609830], [9913, 282257], [10090, 15975], [10116, 288264]], "id": 524}, "interpro": [{"desc": "Fibronectin type III", "id": "IPR003961", "short_desc": "FN3_dom"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Interferon/interleukin receptor domain", "id": "IPR015373", "short_desc": "Interferon/interleukin_rcp_dom"}, {"desc": "Interferon alpha/beta receptor 1", "id": "IPR016669", "short_desc": "Interferon_alpha/beta_rcpt-1"}, {"desc": "Fibronectin type III superfamily", "id": "IPR036116", "short_desc": "FN3_sf"}], "ipi": ["IPI00012877", "IPI00853633", "IPI00877141", "IPI00877162", "IPI00953088", "IPI01012023"], "map_location": "21q22.11", "name": "interferon alpha and beta receptor subunit 1", "other_names": ["CRF2-1", "IFN-R-1", "IFN-alpha/beta receptor 1", "IFNalpha/beta receptor 1", "alpha-type antiviral protein", "beta-type antiviral protein", "cytokine receptor class-II member 1", "cytokine receptor family 2 member 1", "interferon (alpha, beta and omega) receptor 1", "interferon alpha/beta receptor 1", "interferon receptor 1", "interferon-alpha/beta receptor alpha chain", "interferon-beta receptor 1", "type I interferon receptor 1"], "pantherdb": {"HGNC": "5432", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "107658", "ortholog_type": "LDO", "panther_family": "PTHR20859", "taxid": 10090, "uniprot_kb": "P33896"}, {"RGD": "1305399", "ortholog_type": "LDO", "panther_family": "PTHR20859", "taxid": 10116, "uniprot_kb": "D3ZDS9"}, {"Ensembl": "ENSGALG00000030363", "ortholog_type": "LDO", "panther_family": "PTHR20859", "taxid": 9031, "uniprot_kb": "A0A1D5PRB3"}, {"ZFIN": "ZDB-GENE-050909-1", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "F1QA77"}, {"ZFIN": "ZDB-GENE-070905-3", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "B0S652"}], "uniprot_kb": "P17181"}, "pathway": {"biocarta": [{"id": "ifnapathway", "name": "ifn alpha signaling pathway"}, {"id": "ranklpathway", "name": "bone remodeling"}], "kegg": [{"id": "hsa04060", "name": "Cytokine-cytokine receptor interaction - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04217", "name": "Necroptosis - Homo sapiens (human)"}, {"id": "hsa04380", "name": "Osteoclast differentiation - Homo sapiens (human)"}, {"id": "hsa04620", "name": "Toll-like receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04621", "name": "NOD-like receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)"}, {"id": "hsa04650", "name": "Natural killer cell mediated cytotoxicity - Homo sapiens (human)"}, {"id": "hsa05160", "name": "Hepatitis C - Homo sapiens (human)"}, {"id": "hsa05161", "name": "Hepatitis B - Homo sapiens (human)"}, {"id": "hsa05162", "name": "Measles - Homo sapiens (human)"}, {"id": "hsa05164", "name": "Influenza A - Homo sapiens (human)"}, {"id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)"}, {"id": "hsa05167", "name": "Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)"}, {"id": "hsa05168", "name": "Herpes simplex virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}], "pid": {"id": "cd8tcrdownstreampathway", "name": "Downstream signaling in na&#xef;ve CD8+ T cells"}, "reactome": [{"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-909733", "name": "Interferon alpha/beta signaling"}, {"id": "R-HSA-909733", "name": "Interferon alpha/beta signaling"}, {"id": "R-HSA-912694", "name": "Regulation of IFNA/IFNB signaling"}, {"id": "R-HSA-912694", "name": "Regulation of IFNA/IFNB signaling"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-9679191", "name": "Potential therapeutics for SARS"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9694516", "name": "SARS-CoV-2 Infection"}, {"id": "R-HSA-9705671", "name": "SARS-CoV-2 activates/modulates innate and adaptive immune responses"}, {"id": "R-HSA-9705683", "name": "SARS-CoV-2-host interactions"}, {"id": "R-HSA-9820952", "name": "Respiratory Syncytial Virus Infection Pathway"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}, {"id": "R-HSA-9833109", "name": "Evasion by RSV of host interferon responses"}, {"id": "R-HSA-9833110", "name": "RSV-host interactions"}], "wikipathways": [{"id": "WP12", "name": "Osteoclast Signaling"}, {"id": "WP1449", "name": "Regulation of toll-like receptor signaling pathway"}, {"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4197", "name": "Immune response to tuberculosis"}, {"id": "WP4538", "name": "Regulatory circuits of the STAT3 signaling pathway"}, {"id": "WP4558", "name": "Overview of interferons-mediated signaling pathway"}, {"id": "WP4666", "name": "Hepatitis B infection"}, {"id": "WP4868", "name": "Type I interferon induction and signaling during SARS-CoV-2 infection"}, {"id": "WP4880", "name": "Host-pathogen interaction of human coronaviruses - interferon induction"}, {"id": "WP4912", "name": "SARS coronavirus and innate immunity"}, {"id": "WP5039", "name": "SARS-CoV-2 innate immunity evasion and cell-specific immune response"}, {"id": "WP585", "name": "Interferon type I signaling pathways"}, {"id": "WP75", "name": "Toll-like Receptor Signaling Pathway"}]}, "pdb": ["3S98", "3SE3", "3SE4", "4PO6"], "pfam": ["PF01108", "PF09294"], "pharmgkb": "PA29670", "pharos": {"target_id": 19570, "tdl": "Tclin"}, "pir": ["A32694", "S41602"], "prosite": "PS50853", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF251179", "relationship": "is"}, {"id": "GNF251180", "relationship": "is"}, {"id": "GNF251181", "relationship": "is"}, {"id": "GNF251182", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF163127", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF032130", "relationship": "is"}, {"id": "GNF041558", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF084876", "relationship": "is"}, {"id": "GNF084877", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054233", "relationship": "is"}, {"id": "GNF074332", "relationship": "is"}, {"id": "GNF078749", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF063759", "relationship": "is"}, {"id": "GNF063760", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF006944", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF244019", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF096952", "relationship": "is"}, {"id": "GNF136607", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000021.9", "NC_060945.1"], "protein": ["NP_000620.2", "NP_001371427.1", "NP_001371428.1", "NP_001371429.1", "NP_001371430.1", "NP_001371431.1", "NP_001371432.1", "NP_001371433.1"], "rna": ["NM_000629.3", "NM_001384498.1", "NM_001384499.1", "NM_001384500.1", "NM_001384501.1", "NM_001384502.1", "NM_001384503.1", "NM_001384504.1"], "translation": [{"protein": "NP_001371429.1", "rna": "NM_001384500.1"}, {"protein": "NP_001371427.1", "rna": "NM_001384498.1"}, {"protein": "NP_001371433.1", "rna": "NM_001384504.1"}, {"protein": "NP_001371428.1", "rna": "NM_001384499.1"}, {"protein": "NP_001371432.1", "rna": "NM_001384503.1"}, {"protein": "NP_000620.2", "rna": "NM_000629.3"}, {"protein": "NP_001371430.1", "rna": "NM_001384501.1"}, {"protein": "NP_001371431.1", "rna": "NM_001384502.1"}]}, "reporter": {"HG-U133_Plus_2": ["204191_at", "225661_at", "225669_at", "236478_at"], "HG-U95Av2": "1157_s_at", "HG-U95B": "48583_at", "HTA-2_0": ["TC21000128.hg.1", "TC21000933.hg.1"], "HuEx-1_0": "3918574", "HuGene-1_1": "8068266", "HuGene-2_1": "16922260"}, "retired": 284829, "summary": "The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family and functions as an antiviral factor. [provided by RefSeq, Jul 2020].", "symbol": "IFNAR1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334081"}, "unigene": "Hs.529400", "uniprot": {"Swiss-Prot": "P17181", "TrEMBL": ["A0A8V8TQJ9", "A0A494C0K3", "A0A494C0P2", "A0A994J4B0", "A0A494C0E2", "C9J114", "A0A994J479", "A0A494BZU5", "A0A994J6V0", "A0A8V8TQK8", "A0A994J6F9", "A0A994J3P7", "A0A994J6F6"]}, "wikipedia": {"url_stub": "IFNAR1"}}